These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38962752)

  • 1. Evidence for inflammation in normal-appearing brain regions in patients with growing sporadic vestibular schwannoma: A PET study.
    Alfaifi B; Hinz R; Jackson A; Wadeson A; Pathmanaban ON; Hammerbeck-Ward C; Rutherford SA; King AT; Lewis D; Coope DJ
    Neurooncol Adv; 2024; 6(1):vdae094. PubMed ID: 38962752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.
    Lewis D; Roncaroli F; Agushi E; Mosses D; Williams R; Li KL; Zhu X; Hinz R; Atkinson R; Wadeson A; Hulme S; Mayers H; Stapleton E; Lloyd SKL; Freeman SR; Rutherford SA; Hammerbeck-Ward C; Evans DG; Pathmanaban O; Jackson A; King AT; Coope DJ
    Neuro Oncol; 2019 Feb; 21(3):314-325. PubMed ID: 30388263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches.
    Su Z; Herholz K; Gerhard A; Roncaroli F; Du Plessis D; Jackson A; Turkheimer F; Hinz R
    Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1406-19. PubMed ID: 23715902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study.
    Pitombeira MS; Koole M; Campanholo KR; Souza AM; Duran FLS; Solla DJF; Mendes MF; Pereira SLA; Rimkus CM; Busatto GF; Callegaro D; Buchpiguel CA; de Paula Faria D
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4551-4566. PubMed ID: 35838758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 18-kDa mitochondrial translocator protein in human gliomas: an 11C-(R)PK11195 PET imaging and neuropathology study.
    Su Z; Roncaroli F; Durrenberger PF; Coope DJ; Karabatsou K; Hinz R; Thompson G; Turkheimer FE; Janczar K; Du Plessis D; Brodbelt A; Jackson A; Gerhard A; Herholz K
    J Nucl Med; 2015 Apr; 56(4):512-7. PubMed ID: 25722450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.
    Dickens AM; Vainio S; Marjamäki P; Johansson J; Lehtiniemi P; Rokka J; Rinne J; Solin O; Haaparanta-Solin M; Jones PA; Trigg W; Anthony DC; Airas L
    J Nucl Med; 2014 Mar; 55(3):466-72. PubMed ID: 24516258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats.
    Sridharan S; Lepelletier FX; Trigg W; Banister S; Reekie T; Kassiou M; Gerhard A; Hinz R; Boutin H
    Mol Imaging Biol; 2017 Feb; 19(1):77-89. PubMed ID: 27481358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11)C-[R]-PK11195 PET.
    Kumar A; Muzik O; Shandal V; Chugani D; Chakraborty P; Chugani HT
    J Neuroinflammation; 2012 Oct; 9():232. PubMed ID: 23035793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals.
    Laaksonen S; Saraste M; Nylund M; Hinz R; Snellman A; Rinne J; Matilainen M; Airas L
    Front Neurol; 2024; 15():1352116. PubMed ID: 38445263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
    Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
    Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum neurofilament light with microglial activation in multiple sclerosis.
    Saraste M; Matilainen M; Vuorimaa A; Laaksonen S; Sucksdorff M; Leppert D; Kuhle J; Airas L
    J Neurol Neurosurg Psychiatry; 2023 Sep; 94(9):698-706. PubMed ID: 37130728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Analysis of 11C-PBR28 in the Rat Model of Herpes Encephalitis: Comparison with (R)-11C-PK11195.
    Parente A; Feltes PK; Vállez García D; Sijbesma JW; Moriguchi Jeckel CM; Dierckx RA; de Vries EF; Doorduin J
    J Nucl Med; 2016 May; 57(5):785-91. PubMed ID: 26823567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
    Giannetti P; Politis M; Su P; Turkheimer FE; Malik O; Keihaninejad S; Wu K; Waldman A; Reynolds R; Nicholas R; Piccini P
    Brain; 2015 Jan; 138(Pt 1):110-9. PubMed ID: 25416179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis.
    van der Doef TF; de Witte LD; Sutterland AL; Jobse E; Yaqub M; Boellaard R; de Haan L; Eriksson J; Lammertsma AA; Kahn RS; van Berckel BN
    NPJ Schizophr; 2016; 2():16031. PubMed ID: 27602389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
    Takano A; Piehl F; Hillert J; Varrone A; Nag S; Gulyás B; Stenkrona P; Villemagne VL; Rowe CC; Macdonell R; Tawil NA; Kucinski T; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Halldin C
    EJNMMI Res; 2013 Apr; 3(1):30. PubMed ID: 23618062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natalizumab treatment reduces microglial activation in the white matter of the MS brain.
    Sucksdorff M; Tuisku J; Matilainen M; Vuorimaa A; Smith S; Keitilä J; Rokka J; Parkkola R; Nylund M; Rinne J; Rissanen E; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e574. PubMed ID: 31355310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study.
    Hosoya T; Fukumoto D; Kakiuchi T; Nishiyama S; Yamamoto S; Ohba H; Tsukada H; Ueki T; Sato K; Ouchi Y
    J Neuroinflammation; 2017 Mar; 14(1):69. PubMed ID: 28356120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.